The largest database of trusted experimental protocols

Rp hplc

Manufactured by Agilent Technologies
Sourced in United States

RP-HPLC, or Reverse-Phase High-Performance Liquid Chromatography, is a widely used analytical technique for the separation and identification of various chemical compounds. It is a versatile instrument that utilizes a non-polar stationary phase and a polar mobile phase to separate analytes based on their hydrophobic interactions. The core function of RP-HPLC is to provide efficient and accurate separation and quantification of complex mixtures, making it a valuable tool for a wide range of applications, including pharmaceutical, environmental, and food analysis.

Automatically generated - may contain errors

29 protocols using rp hplc

1

Synthesis and Purification of pBD114 Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pBD114 mature peptide amino acid sequence was obtained from NCBI entry number NP_001123445.1 and was synthesized using the solid-phase method with minor modifications [56 (link)]. The reaction conditions for pBD114 extension were as follows: 3-fold excess of Fmoc protecting group amino acids; 3-fold excess of HBTU/HOBT as coupling reagents; 6-fold excess of N, N-Diisopropylethylamine, and DMF as a solvent. Deprotections were performed using a solution of 20% (v/v) piperidine in DMF. Finally, the pBD114 was cleaved with TFA:H2O:TIS = 95:2.5:2.5 (v/v), and purified using RP-HPLC (Agilent Santa Clara, CA, USA) with a C18 column (21.2 × 250 mm). Purity was analyzed using RP-HPLC (Agilent Santa Clara, CA, USA) with a C18 column (4.6 × 250 mm). The molecular mass was confirmed using electrospray ionization-mass spectrometry (EI-MS, LCMS-2020, Shimadzu, Kyoto, Japan).
+ Open protocol
+ Expand
2

Characterization and Stability of Rg3/Lipos

Check if the same lab product or an alternative is used in the 5 most similar protocols
For TEM analysis, Rg3/Lipos (0.3 μg) were placed on a 300-mesh copper grid and air-dried. After washing the grid three times with distilled water, the samples were stained with 2% uranyl acetate solution. Excess uranyl acetate was removed by washing and the grids were observed using a Bio-TEM instrument (Tecnai G 2 Spirit Twin; FEO, USA). For aqueous stability assay, Rg3/Lipos (10 μg) in PBS solution were stored at 4°C and -18°C for predetermined time intervals (1, 4, 7, 10, and 14 days). The sizes of the incubated Rg3/Lipos were measured using DLS.
To determine the encapsulation efficiency, Rg3/Lipos were purified by dialysis to remove free Rg3(S) and the solvent. After freeze-drying, the resulting powder was dissolved in 500 μl methanol and the amount of Rg3(S) was analyzed using RP-HPLC (Agilent Technologies, USA) equipped with a diode-array detector (Agilent Technologies) on a Varian polar C18 reverse-phase column (4.60 × 250 mm, 0.45 μm; Varian, USA) to calculate Rg3(S) and lecithin [7 (link)]. The mobile phase consisted of 0.1% formic acid in water and acetonitrile [14 (link)]. The flow rate was set at 1 ml/min. The eluent was analyzed at a wavelength of 205 nm. The encapsulation efficiency was calculated as follows: Rg3(S) encapsulation efficiency (%) = encapsulated amount of Rg3(S)/initial amount of Rg3(S) × 100.
+ Open protocol
+ Expand
3

Extraction and Characterization of Purple Speckled Kidney Bean Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The purple speckled kidney bean, which was produced in Heilongjiang Province in China, was provided by the National Cereal Engineering Technology Research Center in Daqing, Heilongjiang Province.
Pepsin (3,000 U/g) and trypsin (74,000 U/g) were purchased from Germany's Saiguo Biotechnology Co., Ltd. The HPD-400, HPD-400A, and XAD-7HP resins were purchased from Cangzhou Baoen Adsorption Material Technology Co., Ltd. Potassium sodium tartrate was purchased from Liaoning Quanrui Reagent Co., Ltd. Anhydrous ethanol was purchased from Shandong Deyan Chemical Co., Ltd. DPPH, ferrous sulfate, and ferrous chloride were of analytical grade and were purchased from Aladdin Reagent Co., Ltd. The PHS.2C precision pH meter was purchased from Mettler Toledo, USA. RP-HPLC was purchased from Agilent, USA.
+ Open protocol
+ Expand
4

Automated Synthesis of Peptides with Disulfide Bonds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides were synthesized using an automated peptide synthesizer (Biotage, Uppsala, Sweden) in a 0.1 mmol scale by standard protocols for Fmoc solid‐phase synthesis. Rink amide ChemMatrix resin (Biotage) was used as solid phase to obtain C‐terminally amidated peptides. Stearic acid (Sigma‐Aldrich, Munich, Germany) and PEG (PEG1000, polydisperse—Jenkem, Plano, TX; PEG600, monodisperse—Chempep, Wellington, FL) were coupled like standard amino acids, with coupling times of 18 hours and 24 hours, respectively. For the generation of intramolecular disulfide bonds, the peptidyl resin was treated with 1.6 eqv of thallium (III) trifluoroacetate (Sigma‐Aldrich) in DMF (Sigma‐Aldrich) for 30 minutes.21 Cleavage from resin was done following standard protocol (95% trifluoroacetic acid [TFA] [Sigma‐Aldrich], 2.5% TIS [Sigma‐Aldrich], 2.5% MQ water). The peptides were purified by RP‐HPLC (Agilent, Santa Clara, CA) using a C3 column and 20%‐90% acetonitrile gradient in water (0.1% TFA). Molecular weights of the peptides were analyzed by MALDI‐TOF mass‐spectrometry, and purities were determined by UPLC (Waters, Milford, MA). Disulfide bond formation was confirmed with Ellmann's test (Ellmann's reagent, Sigma‐Aldrich).
+ Open protocol
+ Expand
5

Synthesis and Purification of Lipid Conjugates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Lipid-dansyl and Lipid-DNP conjugates were synthesized using Fmoc chemistry on solid support using NovaPEG Rink Amide resin as previously described.21 (link) The synthetic scheme is described in Figure S-1. Briefly, protected molecules with terminal acid groups were activated with HBTU and a four-fold molar excess of DIEA for 5 minutes and then conjugated to the resin over 30 minutes. Fmoc was deprotected with 20% piperidine in DMF and IvDdE was deprotected using 2% hydrazine in DMF. Deprotection and coupling steps were monitored with Kaiser tests. Lipid-hapten conjugates were cleaved using a 95/2.5/2.5 TFA/water/TIS solution for 45 minutes. Lipid hapten molecules were purified using 1200 Agilent RP-HPLC using a semi-preparative Zorbax C3 column. A two phase water and 70/20/10 IPA/ACN/water mix was used for purification with a gradient of 60–100% IPA mix over 10 minutes at a flow rate of 3 mL min−1. Hapten-amino acid conjugates were purified using a Zorbax C18 column, using a two phase water/ACN system with a gradient of 20–50 % ACN in 10 minutes. The product was confirmed using a Bruker microTOF II mass spectrometer (Figure S-2). Absorbance peaks at 220nm and 280nm were collected and verified for purity with analytical injections (>95%) (Figure S-3).
+ Open protocol
+ Expand
6

Purification of Plantaricin YKX

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plantaricin YKX was purified by protein precipitation, SP-Sepharose cation-exchange chromatography (80 × 2.0 cm, Sigma, Santa Clara, CA, United States), and reversed-phase high-performance liquid chromatography (RP-HPLC) (Agilent Technologies, Palo Alto, CA, United States). First, L. plantarum cells (50 mL) were cultured in MRS (1 L) at 30°C for 24 h. Next, the cell-free supernatants were concentrated to 1/5th of the initial volume using a rotavapor (RV-8V, IKA, Staufen, Germany). After that, ammonium sulfate was added to 50% (v/v) saturation and stirred overnight at 4°C. The obtained residue was suspended in 20 mM disodium hydrogen phosphate-citric acid buffer (pH 5.0), loaded on the SP-Sepharose column, and eluted with the same buffer at 0.5 mL/min. Next, the collected fraction showing the highest activity was scanned to obtain the maximal absorption wavelength and then precipitated with 50% aqueous methanol (v/v) and vortexed for 1 min. Further, it was fractionated using a Dionex UltiMate 3000 HPLC system with a photodiode array detector coupled with an Agilent HC-C18 column (5 μm, 250 mm × 4.6 mm). A linear gradient of ACN/water (10–95%) over 40 min was used for elution at 0.5 mL/min. The antibacterial activity was determined by agar well diffusion assay using A. acidoterrestris DSM3922 as an indicator. The Bradford assay measured the protein concentration.
+ Open protocol
+ Expand
7

Preparation and Characterization of PTX-Loaded Crosslinked Micelles

Check if the same lab product or an alternative is used in the 5 most similar protocols
PT-loaded di-LA-PC micelles were prepared via the slow addition of DMF solution containing PTX and di-LA-PC conjugate to deionized water at rt under constant stirring. Subsequently, the prepared samples were dialyzed for 48 h (MWCO 1000 Da) to remove the unincorporated PTX cross-linked via the addition of a catalytic amount of DTT. Accordingly, crosslinked micelles loaded with PTX drug and a concentration of 0.5 mg PTX per mL was obtained.
The PTX loading content was established via RP-HPLC (Agilent, CA). The detection was performed using a ZORBAX SB-C18 column (150 mm × 4.6 mm, 5 μm) at 25 ± 2 °C and a wavelength of 254 nm. The flow rate was set at 1.0 mL min−1, applying a gradient mobile phase comprised of methanol in water (0–12 min: 60–80%; and 12–20 min: 80–80%) containing 0.1% TFA. The drug loading capacity (DLC) and drug loading efficiency (DLE) were determined based on the following formula:
+ Open protocol
+ Expand
8

Peptide Conjugation and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cyanine5.5 NHS ester (50 mg, 1.4 eq) in DMF (4 mL), DFO (25 mg, 1 eq) in DMSO (4 mL), or SPDP (25 mg, 1 eq) in NMP (4 mL), were added to the resin (0.05 mmoL, 1 eq) and allowed to react overnight at room temperature. For fluorophore and chelator conjugation, the reactions were performed in the presence of an organic base (DIPEA, 1 mL). The peptides were then removed from the resin using a cleaving cocktail (5 mL) containing TFA/thioanisole/1,2-ethandithiol/anisole (90:5:3:2) for 4 hours and precipitated in methyl-tert-butyl ether. The resulting peptides (Cy-peptide, DFO-peptide, and SPDP-peptide) were purified to >98% purity using reverse-phase high-performance liquid chromatography (rp-HPLC; Agilent) and were characterized by MALDI-TOF analysis (Tufts Medical School) to confirm their molecular weights.
+ Open protocol
+ Expand
9

Protein Purity and Molecular Weight Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein molecular weight and purity were determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The concentration of the used acrylamide and separation gel was 5% and 16%, respectively [54 (link),55 (link)]. The molecular weight of the protein was determined in comparison to the Unstained Protein 26610 molecular marker kit (Thermo Fisher Scientific, Madison, CT, USA). The protein was visualized by staining the gel with Coomassie Brilliant Blue-250 (Thermo Fisher Scientific, Madison, CT, USA).
Reversed-phase high-performance liquid chromatography (RP-HPLC) is featured by its high resolution and separation efficiency. The protein purity was further confirmed by using RP-HPLC (Agilent, Foster City, CA, USA). The protein was loaded onto 5 μm ZORBAX® 300SB-C8 column (4.6 × 150 mm, Agilent, Foster City, CA, USA) linked to a series 1100 HPLC system which was pre-equilibrated with 0.1% (v/v) TFA for 2 min. In the solvent, there were solvent A and solvent B, which were 0.1% (v/v) TFA in Milli-Q water and 0.1% (v/v) TFA in acetonitrile, respectively. The flow rate was set to 1 mL/min, and the linear gradient process for solvent A (40–90%) and B (90–100%) was 30 min and 10 min, respectively. Then, the protein was kept in 100% solvent B for 5 min. The detection wavelength was 280 nm and the column temperature was 30 °C [56 (link),57 (link)].
+ Open protocol
+ Expand
10

Solid-Phase Synthesis of Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides (Tyr-Pro-Trp-Phe-Cys-NH2) were prepared by manual solid-phase synthesis, using Rink Amide resin and Fmoc (Sigma Aldrich St Louis, MO, USA) protection, as described by Fichna et al. [23 (link)]. After cleavage from resin by TFA/TIS treatment (EMD Milipore Corp. Billerica, MA, USA), the crude peptides were purified by preparative RP HPLC (Agilent Technologies, Foster City, CA, USA). The purity of synthetase peptides was established by analytical RP HPLC.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!